Transcriptional mechanisms of phenotypic plasticity in glioblastoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Prospective screening study demonstrates excellent EsoGuard sensitivity of 87.5% and negative predictive value (NPV) of 98.6% Previously announced positive data from a separate prospective VA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback